Literature DB >> 11244048

B cell development pathways.

R R Hardy1, K Hayakawa.   

Abstract

B cell development is a highly regulated process whereby functional peripheral subsets are produced from hematopoietic stem cells, in the fetal liver before birth and in the bone marrow afterward. Here we review progress in understanding some aspects of this process in the mouse bone marrow, focusing on delineation of the earliest stages of commitment, on pre-B cell receptor selection, and B cell tolerance during the immature-to-mature B cell transition. Then we note some of the distinctions in hematopoiesis and pre-B selection between fetal liver and adult bone marrow, drawing a connection from fetal development to B-1/CD5(+) B cells. Finally, focusing on CD5(+) cells, we consider the forces that influence the generation and maintenance of this distinctive peripheral B cell population, enriched for natural autoreactive specificities that are encoded by particular germline V(H)-V(L) combinations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244048     DOI: 10.1146/annurev.immunol.19.1.595

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  399 in total

1.  Age-dependent increase of peritoneal B-1b B cells in SCID mice.

Authors:  Kirk S Hinkley; Rod J Chiasson; Tracey K Prior; James E Riggs
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

2.  X-chromosome-linked immune-deficient mice have B-1b cells.

Authors:  J Riggs; K Howell; B Matechin; R Matlack; A Pennello; R Chiasson
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

Review 3.  Arginine: an unusual dietary requirement of pre-B lymphocytes?

Authors:  Tucker W LeBien
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 4.  Plasticity and maintenance of hematopoietic stem cells during development.

Authors:  Suman Kanji; Vincent J Pompili; Hiranmoy Das
Journal:  Recent Pat Biotechnol       Date:  2011-04

Review 5.  Cell cycle control mechanisms in B-1 and B-2 lymphoid subsets.

Authors:  Michael J Piatelli; Debra Tanguay; Thomas L Rothstein; Thomas C Chiles
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  Impaired B cell development and function in mice with a targeted disruption of the homeobox gene Hex.

Authors:  Clifford W Bogue; Ping-Xia Zhang; James McGrath; Harris C Jacobs; Ramsay L Fuleihan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-08       Impact factor: 11.205

7.  Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Authors:  Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.

Authors:  Zhaohui Gu; Michelle L Churchman; Kathryn G Roberts; Ian Moore; Xin Zhou; Joy Nakitandwe; Kohei Hagiwara; Stephane Pelletier; Sebastien Gingras; Hartmut Berns; Debbie Payne-Turner; Ashley Hill; Ilaria Iacobucci; Lei Shi; Stanley Pounds; Cheng Cheng; Deqing Pei; Chunxu Qu; Scott Newman; Meenakshi Devidas; Yunfeng Dai; Shalini C Reshmi; Julie Gastier-Foster; Elizabeth A Raetz; Michael J Borowitz; Brent L Wood; William L Carroll; Patrick A Zweidler-McKay; Karen R Rabin; Leonard A Mattano; Kelly W Maloney; Alessandro Rambaldi; Orietta Spinelli; Jerald P Radich; Mark D Minden; Jacob M Rowe; Selina Luger; Mark R Litzow; Martin S Tallman; Janis Racevskis; Yanming Zhang; Ravi Bhatia; Jessica Kohlschmidt; Krzysztof Mrózek; Clara D Bloomfield; Wendy Stock; Steven Kornblau; Hagop M Kantarjian; Marina Konopleva; Williams E Evans; Sima Jeha; Ching-Hon Pui; Jun Yang; Elisabeth Paietta; James R Downing; Mary V Relling; Jinghui Zhang; Mignon L Loh; Stephen P Hunger; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-01-14       Impact factor: 38.330

9.  Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage.

Authors:  Zheng Zhang; Claudiu V Cotta; Robert P Stephan; Cristina G deGuzman; Christopher A Klug
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

10.  TSPAN33 is a novel marker of activated and malignant B cells.

Authors:  Van Phi Luu; Peter Hevezi; Felipe Vences-Catalan; José Luis Maravillas-Montero; Clayton Alexander White; Paolo Casali; Luis Llorente; Juan Jakez-Ocampo; Guadalupe Lima; Natalia Vilches-Cisneros; Juan Pablo Flores-Gutiérrez; Leopoldo Santos-Argumedo; Albert Zlotnik
Journal:  Clin Immunol       Date:  2013-08-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.